SlideShare a Scribd company logo
• Introduction
• Aims of the study
• Patients and Methods
• Results & Discussion
• Conclusions & Recommendations.
Bronchial Asthma
• Asthma is a common chronic disease, causing
considerable morbidity.
• It is caused by chronic inflammation of lung airways
with increased airway responsiveness and airflow
obstruction.
• In 2007, 9.6 million children (13.1%) had been
diagnosed with asthma in their lifetimes.
• Boys (14% vs 10%) girls
• Children in poor families (16% vs 10% not poor) are
more likely to have asthma.
• Approximately 80% of all asthmatic patients report
disease onset prior to 6 yr of age.
Bronchial Asthma
• The rise in asthma and allergic disease among
children is a matter of worldwide concern.
• Many authors have argued that the changes in
diet may have been an important determinant
of increased susceptibility to asthma.
Magnesium
• Magnesium (Mg) is the fourth most abundant ion
in the human body; of which 50% is stored in the
• bones, 49% in cells and the remaining 1% in the
serum.
• Mg is involved in the structure of many enzymes
in the body and plays a role in intracellular
reactions.
• Mg is crucial for normal neuromuscular activities.
• Magnesium deficiency is associated with
increased contractility of smooth muscle cells
including bronchiolar resulting in bronchospasm.
To determine prevalence of
hypomagnesemia among asthmatic children
Comparison between mean Serum
Magnesium levels in Asthmatic and
control group
To determine
association between
mean Serum
Magnesium and BMI
of Asthmatic patients
Comparison between mean Serum
Magnesium levels & duration of
Asthma
.
Aims of the study
To determine association
between mean Serum
Magnesium levels & use of
medications (controller) in
Asthmatics.
To determine
association between
mean Serum
Magnesium levels &
severity of Asthma.
• study location
• Heevi Pediatric Teaching Hospital /
Duhok/Kurdistan/Iraq.
• Study Design
• A case – control study
• Duration of Data collection.
• January1st 2014 and January1st 2015
• Selection of the study participants:
• 200 participants from both genders ; their
ages range between 1 to 15 years.
• Patient group: 100 asthmatic patients
• Control group: 100 healthy children.
Patients and Methods
• Inclusion Criteria:
• Diagnosis of asthma and severity of disease
were identified based on the Global Initiative
for Asthma (GINA) guideline criteria.
• Exclusion Criteria:
• Any patient with localized wheezing,
dehydration, fever, pneumonia, renal, hepatic
or cardiac dysfunction.
Patients and Methods
Data collection
• A pre designed questionnaire was filled and
all data were kept confidential.
• For each participant the weight, height and
BMI (body mass index) were measured.
Estimation of serum Magnesium
• A blood sample was collected from patients
and controls for the measurement of serum
Magnesium by using atomic absorption
spectrophotometer.
• Normal Serum Mg: (1.5-2.3 mg/dL)
• Magnesium (Mg): level of < 1.5 mg/dl was
considered hypomagnesemia
Data Analysis
• SPSS (statistical package for the social
sciences) for windows version 19.
• A P-value of less than 0.05 was considered to
be statistically significant.
Patients and Methods
The distribution of Age & Gender for both
Asthmatic and controls
Age (years)
Asthmatic patients Control Group
No.(%) Male Female No. Male Female
1 - <3 years 40(40%) 27(27%) 13(13%) 25(25%) 18(18%) 7(7%)
3 - <5 years 22(22%) 16(16%) 6(6%) 14(14%) 9(9%) 5(5%)
5 - <10 years 29(29%) 19(19%) 10(10%) 36(36%) 19(19%) 17(17%)
10-15 years 9(9%) 6(6%) 3(3%) 25(25%) 15(15%) 10(10%)
Total 100(100%) 68(68%) 32(32%) 100(100%) 61(61%) 39(39%)
The mean Serum Mg levels in Asthmatic and
control group
Groups
No.
(%)
Serum Mg
level(mg/dl) P-value
Mean(±SD.)
Asthmatic patient 100 1.91± 0.33
0.01
Controls 100 2.03± 0.33
Comparison between Mg levels in Asthmatic
and control group
Serum Magnesium
Asthmatic
patients
Control
group
Total
Low S.Mg(<1.5 µg/dl) 9(9%) 1(1%) 10(5%)
Normal S.Mg (1.5-2.3 mg/dL) 91(91%) 99(99%) 190(95%)
Total 100(100%) 100(100%) 200(100%)
X2=8.36 df=2 P=0.01
Comparison between mean Serum Serum
Magnesium levels & severity of Asthma.
Severity of
Asthma
No. (%)
Serum Mg level(
mg/dl) P-value
Mean(±SD.)
Intermittent 67(67%) 1.96±0.33
0.05
Mild persistent 20 (20%) 1.85±0.26
Moderate
persistent
10 (10%) 1.79±0.42
Severe persistent 3(3%) 1.50±0.10
Total 100 (100%) 1.91±0.33
Comparison between mean Magnesium levels &
duration of Asthma.
Duration of Asthma No.(%)
Serum Mg level(
mg/dl) P-value
Mean(±SD.)
< 1 year 28 (28%) 1.97±0.27
0.1
1 - <3 years 48 (48%) 1.91±0.33
3- <5 years 11 (11%) 1.87±0.36
>5 years 13 (13%) 1.72±0.44
Total 100 (100%) 1.91±0.33
The relation between mean Serum
Magnesium and BMI of Asthmatic patients
BMI No.
Serum D3
level(µg/dl)
P-
value
Mean(±SD.)
Under weight
<5%
21(21%) 1.97±0.25
0.3
Normal
5% to 85%
57 (57%) 1.90±0.36
Overweight
85% to 95%
13 (13%) 1.78±0.30
Obese
>95%
9 (9%) 2.00±0.32
Total 100 (100%) 1.91±0.33
The Comparison between mean Serum Magnesium
levels & use of medications (controller) in
Asthmatics.
Drugs No.(%)
Serum Mg level ( mg/dl)
P-value
Mean(±SD.)
Steroid as controller medications
Used steroid 20 (20%) 1.92±0.37
0.7
Not used steroid 80 (80%) 1.90±0.30
Bronchodilators as controller medications
Use 31 (31%) 1.91±0.34
0.9
Not used 59 (59%) 1.90±0.31
Total 100(100%) 1.91±0.33
Prevalence of Low Mg Level in
Asthmatic patients
Serum Magnesium level was found to be significantly lower
in asthmatic children as compared to the control group
Ukraine
Egypt
Turkey
No significant differences between patients and controls
Spain
Iran
Possible Explanation of Magnesium
Deficiency in Asthmatics
• Magnesium is the cofactor of more than 300 enzymes and is
involved in many physiological functions including protein synthesis,
intracellular signal distribution and enzyme catalysis.
• Since it is the natural antagonist of calcium, it provides smooth
muscle relaxation
• In addition, magnesium suppresses the excitability of muscle
fibers by reduction of acetylcholine secretion from motor nerve
terminals.
• Moreover, it inhibits production of inflammatory mediators by
helping stabilization of T-cells and inhibiting mast cell
degranulation.
• Again, it reduces the severity of inflammation in asthma by
stimulating nitric oxide and prostacyclin syntheses.
Possible Explanation of Magnesium
Deficiency in Asthmatics
• Although the cause of hypomagnesemia in
patients with bronchial asthma was unknown,
• It may be related to either low magnesium
intake in asthmatics or increased urinary loss
of magnesium, as a side effect of therapy with
b2- agonist, corticosteroid, and theophylline.
CONCLUSION AND
RECOMMENDATIONS
Conclusions
• Asthmatic Patients have significantly lower
mean Serum Mg levels compared with healthy
controls.
• There is significant difference between mean
Serum Mg levels AND severity of asthma.
• Serum Mg level inversely correlates with the
duration of asthma but not significantly.
• But no statistically significant association were
observed between Serum Mg and BMI.
• No significant change in serum Mg develops with
the use of steroids and bronchodilators in
treatment.
Recommendations
• Magnesium supplementation might be
considered a useful additional intervention for
improving outcome in patients with Asthma.
• A large follow up study is recommended to
look on the effect of Magnesium
supplementation in Asthmatic patients.
• Further extended cohort study is indicated to
look on the relations between the Asthmatic
patients and serum Magnesium level.
THANKS FOR YOUR
ATTENTION

More Related Content

What's hot

Acute Myeloid Leukemia
Acute Myeloid LeukemiaAcute Myeloid Leukemia
Congenital adrenal hyperplasia
Congenital adrenal hyperplasia Congenital adrenal hyperplasia
Congenital adrenal hyperplasia
Manoj Prabhakar
 
Nutritional refeeding syndrome kwashiorkar and marasmus indore pedicon 2014
Nutritional refeeding syndrome kwashiorkar and marasmus indore pedicon 2014Nutritional refeeding syndrome kwashiorkar and marasmus indore pedicon 2014
Nutritional refeeding syndrome kwashiorkar and marasmus indore pedicon 2014
Rajesh Kulkarni
 
Tuberous sclerosis
Tuberous sclerosis Tuberous sclerosis
Tuberous sclerosis
Siva Pesala
 
Sickle cell anemia
Sickle cell anemiaSickle cell anemia
Sickle cell anemia
MohammedAlHinai18
 
2022 Hypertension Lecture (Updated Guidelines).pdf
2022 Hypertension Lecture (Updated Guidelines).pdf2022 Hypertension Lecture (Updated Guidelines).pdf
2022 Hypertension Lecture (Updated Guidelines).pdf
Meccar Moniem Elino
 
Iron deficiency anemia
Iron deficiency anemiaIron deficiency anemia
Iron deficiency anemia
Lavina Belayutham
 
External markers of tuberculosis
External markers of tuberculosisExternal markers of tuberculosis
External markers of tuberculosisKurian Joseph
 
Copy of renal tubular acidosis
Copy of renal tubular acidosisCopy of renal tubular acidosis
Copy of renal tubular acidosisPramod kamble
 
iron deficiency anemia
 iron deficiency anemia iron deficiency anemia
iron deficiency anemia
Mithun Patel
 
Approach to anemia and iron deficiency anemia
Approach to anemia and iron deficiency anemiaApproach to anemia and iron deficiency anemia
Approach to anemia and iron deficiency anemia
Tushar Jagzape
 
Seminar short stature
Seminar short statureSeminar short stature
Seminar short stature
Rakesh Verma
 
Short stature Dr.M.Sucindar
Short stature   Dr.M.SucindarShort stature   Dr.M.Sucindar
Short stature Dr.M.Sucindar
Sucindar M
 
Approach to child with histiocytosis
Approach to child with histiocytosisApproach to child with histiocytosis
Approach to child with histiocytosis
eram sid
 
Cornelia de Lange Syndrome.pptx
Cornelia de Lange Syndrome.pptxCornelia de Lange Syndrome.pptx
Cornelia de Lange Syndrome.pptx
Jovian3
 
Pediatric neurology mcq
Pediatric neurology mcqPediatric neurology mcq
Pediatric neurology mcq
Hari Meshram
 
Thalassemia.by dr narmada
Thalassemia.by dr narmadaThalassemia.by dr narmada
Thalassemia.by dr narmadaNarmada Tiwari
 
Approach to a child with hematuria
Approach to a child with hematuriaApproach to a child with hematuria
Approach to a child with hematuriaSunil Agrawal
 

What's hot (20)

Acute Myeloid Leukemia
Acute Myeloid LeukemiaAcute Myeloid Leukemia
Acute Myeloid Leukemia
 
Congenital adrenal hyperplasia
Congenital adrenal hyperplasia Congenital adrenal hyperplasia
Congenital adrenal hyperplasia
 
Nutritional refeeding syndrome kwashiorkar and marasmus indore pedicon 2014
Nutritional refeeding syndrome kwashiorkar and marasmus indore pedicon 2014Nutritional refeeding syndrome kwashiorkar and marasmus indore pedicon 2014
Nutritional refeeding syndrome kwashiorkar and marasmus indore pedicon 2014
 
Tuberous sclerosis
Tuberous sclerosis Tuberous sclerosis
Tuberous sclerosis
 
Sickle cell anemia
Sickle cell anemiaSickle cell anemia
Sickle cell anemia
 
2022 Hypertension Lecture (Updated Guidelines).pdf
2022 Hypertension Lecture (Updated Guidelines).pdf2022 Hypertension Lecture (Updated Guidelines).pdf
2022 Hypertension Lecture (Updated Guidelines).pdf
 
Iron deficiency anemia
Iron deficiency anemiaIron deficiency anemia
Iron deficiency anemia
 
External markers of tuberculosis
External markers of tuberculosisExternal markers of tuberculosis
External markers of tuberculosis
 
SHORT STATURE
SHORT STATURESHORT STATURE
SHORT STATURE
 
Copy of renal tubular acidosis
Copy of renal tubular acidosisCopy of renal tubular acidosis
Copy of renal tubular acidosis
 
iron deficiency anemia
 iron deficiency anemia iron deficiency anemia
iron deficiency anemia
 
Approach to anemia and iron deficiency anemia
Approach to anemia and iron deficiency anemiaApproach to anemia and iron deficiency anemia
Approach to anemia and iron deficiency anemia
 
Seminar short stature
Seminar short statureSeminar short stature
Seminar short stature
 
Short stature Dr.M.Sucindar
Short stature   Dr.M.SucindarShort stature   Dr.M.Sucindar
Short stature Dr.M.Sucindar
 
Approach to child with histiocytosis
Approach to child with histiocytosisApproach to child with histiocytosis
Approach to child with histiocytosis
 
Cornelia de Lange Syndrome.pptx
Cornelia de Lange Syndrome.pptxCornelia de Lange Syndrome.pptx
Cornelia de Lange Syndrome.pptx
 
Pediatric neurology mcq
Pediatric neurology mcqPediatric neurology mcq
Pediatric neurology mcq
 
Thalassemia.by dr narmada
Thalassemia.by dr narmadaThalassemia.by dr narmada
Thalassemia.by dr narmada
 
Ac nephritic synd
Ac nephritic syndAc nephritic synd
Ac nephritic synd
 
Approach to a child with hematuria
Approach to a child with hematuriaApproach to a child with hematuria
Approach to a child with hematuria
 

Similar to Serum magnesium level in children with bronchial asthma

Seminar Hasil_Nabilla Asmara.pptx
Seminar Hasil_Nabilla Asmara.pptxSeminar Hasil_Nabilla Asmara.pptx
Seminar Hasil_Nabilla Asmara.pptx
Vyan2897
 
Evaporate trial
Evaporate trialEvaporate trial
Evaporate trial
Priyanka Thakur
 
Serum chromium, zinc and testosterone levels in diabetics in
Serum chromium, zinc and testosterone levels in diabetics inSerum chromium, zinc and testosterone levels in diabetics in
Serum chromium, zinc and testosterone levels in diabetics in
Alexander Decker
 
Article on glucose metre
Article on glucose metreArticle on glucose metre
Article on glucose metre
VijayBhasker Velury
 
Sugar Control in ICU
Sugar Control in ICUSugar Control in ICU
Sugar Control in ICU
Muhammad Asim Rana
 
oxidative stress in fibromyalgia syndrome
oxidative stress in fibromyalgia syndromeoxidative stress in fibromyalgia syndrome
oxidative stress in fibromyalgia syndrome
Ghizal Fatima
 
JOURNAL CLUB PRESNTATION laparoscopy1.pptx
JOURNAL  CLUB PRESNTATION laparoscopy1.pptxJOURNAL  CLUB PRESNTATION laparoscopy1.pptx
JOURNAL CLUB PRESNTATION laparoscopy1.pptx
asispodar
 
JOURNAL CLUB hematology.pptx
JOURNAL CLUB hematology.pptxJOURNAL CLUB hematology.pptx
JOURNAL CLUB hematology.pptx
MariaFatima374066
 
2.fens 2019 dr vs sodium_naska
2.fens 2019 dr vs sodium_naska2.fens 2019 dr vs sodium_naska
2.fens 2019 dr vs sodium_naska
EFSA EU
 
Management of cirrhosis for improving survival
Management of cirrhosis for improving survivalManagement of cirrhosis for improving survival
Management of cirrhosis for improving survival
Mahendra Debbarma
 
hypomagnesemia in ICU
hypomagnesemia in ICUhypomagnesemia in ICU
hypomagnesemia in ICU
Bhargav Kiran
 
02 oa hypomagnesemia (1)
02 oa hypomagnesemia (1)02 oa hypomagnesemia (1)
02 oa hypomagnesemia (1)
sekarkt
 
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ingSalon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
tyfngnc
 
Can treating metabolic acidosis of ckd slow decline in eGFR?
Can treating metabolic acidosis of ckd slow decline in eGFR?Can treating metabolic acidosis of ckd slow decline in eGFR?
Can treating metabolic acidosis of ckd slow decline in eGFR?Adeel Rafi Ahmed
 
Proteinuria Evaluation
Proteinuria EvaluationProteinuria Evaluation
Proteinuria Evaluation
tarun kumar
 
Protective effects of n acetylcysteine on aluminum sukumar new 2222 (1)
Protective effects of  n acetylcysteine on aluminum sukumar new 2222 (1)Protective effects of  n acetylcysteine on aluminum sukumar new 2222 (1)
Protective effects of n acetylcysteine on aluminum sukumar new 2222 (1)Sukumar Msuku
 
oxygen therapy in acute MI - journal club
oxygen therapy in acute MI - journal cluboxygen therapy in acute MI - journal club
oxygen therapy in acute MI - journal club
Dr.Amirtha Tom
 
Transthyretin --Novel Biomarker.pptx
Transthyretin --Novel Biomarker.pptxTransthyretin --Novel Biomarker.pptx
Transthyretin --Novel Biomarker.pptx
Pavan Sagar
 
Serum magnesium level in esophageal and lung carcinoma patients
Serum magnesium level in esophageal and lung carcinoma patientsSerum magnesium level in esophageal and lung carcinoma patients
Serum magnesium level in esophageal and lung carcinoma patients
SSR Institute of International Journal of Life Sciences
 
Journal club vitamin c
Journal club vitamin c Journal club vitamin c
Journal club vitamin c Yassin Alsaleh
 

Similar to Serum magnesium level in children with bronchial asthma (20)

Seminar Hasil_Nabilla Asmara.pptx
Seminar Hasil_Nabilla Asmara.pptxSeminar Hasil_Nabilla Asmara.pptx
Seminar Hasil_Nabilla Asmara.pptx
 
Evaporate trial
Evaporate trialEvaporate trial
Evaporate trial
 
Serum chromium, zinc and testosterone levels in diabetics in
Serum chromium, zinc and testosterone levels in diabetics inSerum chromium, zinc and testosterone levels in diabetics in
Serum chromium, zinc and testosterone levels in diabetics in
 
Article on glucose metre
Article on glucose metreArticle on glucose metre
Article on glucose metre
 
Sugar Control in ICU
Sugar Control in ICUSugar Control in ICU
Sugar Control in ICU
 
oxidative stress in fibromyalgia syndrome
oxidative stress in fibromyalgia syndromeoxidative stress in fibromyalgia syndrome
oxidative stress in fibromyalgia syndrome
 
JOURNAL CLUB PRESNTATION laparoscopy1.pptx
JOURNAL  CLUB PRESNTATION laparoscopy1.pptxJOURNAL  CLUB PRESNTATION laparoscopy1.pptx
JOURNAL CLUB PRESNTATION laparoscopy1.pptx
 
JOURNAL CLUB hematology.pptx
JOURNAL CLUB hematology.pptxJOURNAL CLUB hematology.pptx
JOURNAL CLUB hematology.pptx
 
2.fens 2019 dr vs sodium_naska
2.fens 2019 dr vs sodium_naska2.fens 2019 dr vs sodium_naska
2.fens 2019 dr vs sodium_naska
 
Management of cirrhosis for improving survival
Management of cirrhosis for improving survivalManagement of cirrhosis for improving survival
Management of cirrhosis for improving survival
 
hypomagnesemia in ICU
hypomagnesemia in ICUhypomagnesemia in ICU
hypomagnesemia in ICU
 
02 oa hypomagnesemia (1)
02 oa hypomagnesemia (1)02 oa hypomagnesemia (1)
02 oa hypomagnesemia (1)
 
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ingSalon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
 
Can treating metabolic acidosis of ckd slow decline in eGFR?
Can treating metabolic acidosis of ckd slow decline in eGFR?Can treating metabolic acidosis of ckd slow decline in eGFR?
Can treating metabolic acidosis of ckd slow decline in eGFR?
 
Proteinuria Evaluation
Proteinuria EvaluationProteinuria Evaluation
Proteinuria Evaluation
 
Protective effects of n acetylcysteine on aluminum sukumar new 2222 (1)
Protective effects of  n acetylcysteine on aluminum sukumar new 2222 (1)Protective effects of  n acetylcysteine on aluminum sukumar new 2222 (1)
Protective effects of n acetylcysteine on aluminum sukumar new 2222 (1)
 
oxygen therapy in acute MI - journal club
oxygen therapy in acute MI - journal cluboxygen therapy in acute MI - journal club
oxygen therapy in acute MI - journal club
 
Transthyretin --Novel Biomarker.pptx
Transthyretin --Novel Biomarker.pptxTransthyretin --Novel Biomarker.pptx
Transthyretin --Novel Biomarker.pptx
 
Serum magnesium level in esophageal and lung carcinoma patients
Serum magnesium level in esophageal and lung carcinoma patientsSerum magnesium level in esophageal and lung carcinoma patients
Serum magnesium level in esophageal and lung carcinoma patients
 
Journal club vitamin c
Journal club vitamin c Journal club vitamin c
Journal club vitamin c
 

More from Azad Haleem

Climate change, the environment, and rhinologic disease .pptx
Climate change, the environment, and rhinologic disease .pptxClimate change, the environment, and rhinologic disease .pptx
Climate change, the environment, and rhinologic disease .pptx
Azad Haleem
 
Crimean-Congo hemorrhagic fever (CCHF) Approach
Crimean-Congo hemorrhagic fever (CCHF) ApproachCrimean-Congo hemorrhagic fever (CCHF) Approach
Crimean-Congo hemorrhagic fever (CCHF) Approach
Azad Haleem
 
Precocious Puberty in Girl approach and Management
Precocious Puberty in Girl approach and ManagementPrecocious Puberty in Girl approach and Management
Precocious Puberty in Girl approach and Management
Azad Haleem
 
Diagnosis & Management of Hypoglycemia in Children
Diagnosis & Management of Hypoglycemia in ChildrenDiagnosis & Management of Hypoglycemia in Children
Diagnosis & Management of Hypoglycemia in Children
Azad Haleem
 
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Pediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptxPediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptx
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Azad Haleem
 
Neonatal Hypoglycemia approach and Management .pptx
Neonatal Hypoglycemia approach and Management .pptxNeonatal Hypoglycemia approach and Management .pptx
Neonatal Hypoglycemia approach and Management .pptx
Azad Haleem
 
Preterm infants Nutrition .pptx
Preterm infants Nutrition .pptxPreterm infants Nutrition .pptx
Preterm infants Nutrition .pptx
Azad Haleem
 
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptxPreterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Azad Haleem
 
Breastfeeding VS formula feeding .pptx
 Breastfeeding VS formula feeding .pptx Breastfeeding VS formula feeding .pptx
Breastfeeding VS formula feeding .pptx
Azad Haleem
 
Role of Supplements in Growth Failure in Children .pptx
Role of Supplements in Growth Failure in Children .pptxRole of Supplements in Growth Failure in Children .pptx
Role of Supplements in Growth Failure in Children .pptx
Azad Haleem
 
Degludec Insulin therapy in children
Degludec Insulin therapy in childrenDegludec Insulin therapy in children
Degludec Insulin therapy in children
Azad Haleem
 
Viral hemorrhagic fevers.pptx
Viral hemorrhagic fevers.pptxViral hemorrhagic fevers.pptx
Viral hemorrhagic fevers.pptx
Azad Haleem
 
Micronutrient deficiencies in children .pptx
 Micronutrient deficiencies in children  .pptx Micronutrient deficiencies in children  .pptx
Micronutrient deficiencies in children .pptx
Azad Haleem
 
Insulin therapy in children.pptx
Insulin therapy in children.pptxInsulin therapy in children.pptx
Insulin therapy in children.pptx
Azad Haleem
 
Diagnostic test for testicular and ovarian disorders in children 2.pptx
Diagnostic test for testicular and ovarian disorders in children 2.pptxDiagnostic test for testicular and ovarian disorders in children 2.pptx
Diagnostic test for testicular and ovarian disorders in children 2.pptx
Azad Haleem
 
Diagnostic test for Adrenal disorders in children 2.pptx
Diagnostic test for Adrenal disorders in children 2.pptxDiagnostic test for Adrenal disorders in children 2.pptx
Diagnostic test for Adrenal disorders in children 2.pptx
Azad Haleem
 
Diagnostic test for Thyriod disorders in children.pptx
Diagnostic test for Thyriod disorders in children.pptxDiagnostic test for Thyriod disorders in children.pptx
Diagnostic test for Thyriod disorders in children.pptx
Azad Haleem
 
Achondroplasia in children.pptx
Achondroplasia in children.pptxAchondroplasia in children.pptx
Achondroplasia in children.pptx
Azad Haleem
 
Respiratory Syncytial Virus in children
Respiratory Syncytial Virus in childrenRespiratory Syncytial Virus in children
Respiratory Syncytial Virus in children
Azad Haleem
 
Growth failure in Children.pptx
Growth failure in Children.pptxGrowth failure in Children.pptx
Growth failure in Children.pptx
Azad Haleem
 

More from Azad Haleem (20)

Climate change, the environment, and rhinologic disease .pptx
Climate change, the environment, and rhinologic disease .pptxClimate change, the environment, and rhinologic disease .pptx
Climate change, the environment, and rhinologic disease .pptx
 
Crimean-Congo hemorrhagic fever (CCHF) Approach
Crimean-Congo hemorrhagic fever (CCHF) ApproachCrimean-Congo hemorrhagic fever (CCHF) Approach
Crimean-Congo hemorrhagic fever (CCHF) Approach
 
Precocious Puberty in Girl approach and Management
Precocious Puberty in Girl approach and ManagementPrecocious Puberty in Girl approach and Management
Precocious Puberty in Girl approach and Management
 
Diagnosis & Management of Hypoglycemia in Children
Diagnosis & Management of Hypoglycemia in ChildrenDiagnosis & Management of Hypoglycemia in Children
Diagnosis & Management of Hypoglycemia in Children
 
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Pediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptxPediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptx
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
 
Neonatal Hypoglycemia approach and Management .pptx
Neonatal Hypoglycemia approach and Management .pptxNeonatal Hypoglycemia approach and Management .pptx
Neonatal Hypoglycemia approach and Management .pptx
 
Preterm infants Nutrition .pptx
Preterm infants Nutrition .pptxPreterm infants Nutrition .pptx
Preterm infants Nutrition .pptx
 
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptxPreterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
 
Breastfeeding VS formula feeding .pptx
 Breastfeeding VS formula feeding .pptx Breastfeeding VS formula feeding .pptx
Breastfeeding VS formula feeding .pptx
 
Role of Supplements in Growth Failure in Children .pptx
Role of Supplements in Growth Failure in Children .pptxRole of Supplements in Growth Failure in Children .pptx
Role of Supplements in Growth Failure in Children .pptx
 
Degludec Insulin therapy in children
Degludec Insulin therapy in childrenDegludec Insulin therapy in children
Degludec Insulin therapy in children
 
Viral hemorrhagic fevers.pptx
Viral hemorrhagic fevers.pptxViral hemorrhagic fevers.pptx
Viral hemorrhagic fevers.pptx
 
Micronutrient deficiencies in children .pptx
 Micronutrient deficiencies in children  .pptx Micronutrient deficiencies in children  .pptx
Micronutrient deficiencies in children .pptx
 
Insulin therapy in children.pptx
Insulin therapy in children.pptxInsulin therapy in children.pptx
Insulin therapy in children.pptx
 
Diagnostic test for testicular and ovarian disorders in children 2.pptx
Diagnostic test for testicular and ovarian disorders in children 2.pptxDiagnostic test for testicular and ovarian disorders in children 2.pptx
Diagnostic test for testicular and ovarian disorders in children 2.pptx
 
Diagnostic test for Adrenal disorders in children 2.pptx
Diagnostic test for Adrenal disorders in children 2.pptxDiagnostic test for Adrenal disorders in children 2.pptx
Diagnostic test for Adrenal disorders in children 2.pptx
 
Diagnostic test for Thyriod disorders in children.pptx
Diagnostic test for Thyriod disorders in children.pptxDiagnostic test for Thyriod disorders in children.pptx
Diagnostic test for Thyriod disorders in children.pptx
 
Achondroplasia in children.pptx
Achondroplasia in children.pptxAchondroplasia in children.pptx
Achondroplasia in children.pptx
 
Respiratory Syncytial Virus in children
Respiratory Syncytial Virus in childrenRespiratory Syncytial Virus in children
Respiratory Syncytial Virus in children
 
Growth failure in Children.pptx
Growth failure in Children.pptxGrowth failure in Children.pptx
Growth failure in Children.pptx
 

Recently uploaded

Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
kimdan468
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
Mohammed Sikander
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
goswamiyash170123
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 

Recently uploaded (20)

Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 

Serum magnesium level in children with bronchial asthma

  • 1.
  • 2. • Introduction • Aims of the study • Patients and Methods • Results & Discussion • Conclusions & Recommendations.
  • 3. Bronchial Asthma • Asthma is a common chronic disease, causing considerable morbidity. • It is caused by chronic inflammation of lung airways with increased airway responsiveness and airflow obstruction. • In 2007, 9.6 million children (13.1%) had been diagnosed with asthma in their lifetimes. • Boys (14% vs 10%) girls • Children in poor families (16% vs 10% not poor) are more likely to have asthma. • Approximately 80% of all asthmatic patients report disease onset prior to 6 yr of age.
  • 4. Bronchial Asthma • The rise in asthma and allergic disease among children is a matter of worldwide concern. • Many authors have argued that the changes in diet may have been an important determinant of increased susceptibility to asthma.
  • 5. Magnesium • Magnesium (Mg) is the fourth most abundant ion in the human body; of which 50% is stored in the • bones, 49% in cells and the remaining 1% in the serum. • Mg is involved in the structure of many enzymes in the body and plays a role in intracellular reactions. • Mg is crucial for normal neuromuscular activities. • Magnesium deficiency is associated with increased contractility of smooth muscle cells including bronchiolar resulting in bronchospasm.
  • 6. To determine prevalence of hypomagnesemia among asthmatic children Comparison between mean Serum Magnesium levels in Asthmatic and control group To determine association between mean Serum Magnesium and BMI of Asthmatic patients Comparison between mean Serum Magnesium levels & duration of Asthma . Aims of the study To determine association between mean Serum Magnesium levels & use of medications (controller) in Asthmatics. To determine association between mean Serum Magnesium levels & severity of Asthma.
  • 7. • study location • Heevi Pediatric Teaching Hospital / Duhok/Kurdistan/Iraq. • Study Design • A case – control study • Duration of Data collection. • January1st 2014 and January1st 2015
  • 8. • Selection of the study participants: • 200 participants from both genders ; their ages range between 1 to 15 years. • Patient group: 100 asthmatic patients • Control group: 100 healthy children. Patients and Methods
  • 9. • Inclusion Criteria: • Diagnosis of asthma and severity of disease were identified based on the Global Initiative for Asthma (GINA) guideline criteria. • Exclusion Criteria: • Any patient with localized wheezing, dehydration, fever, pneumonia, renal, hepatic or cardiac dysfunction. Patients and Methods
  • 10. Data collection • A pre designed questionnaire was filled and all data were kept confidential. • For each participant the weight, height and BMI (body mass index) were measured.
  • 11. Estimation of serum Magnesium • A blood sample was collected from patients and controls for the measurement of serum Magnesium by using atomic absorption spectrophotometer. • Normal Serum Mg: (1.5-2.3 mg/dL) • Magnesium (Mg): level of < 1.5 mg/dl was considered hypomagnesemia
  • 12. Data Analysis • SPSS (statistical package for the social sciences) for windows version 19. • A P-value of less than 0.05 was considered to be statistically significant. Patients and Methods
  • 13.
  • 14. The distribution of Age & Gender for both Asthmatic and controls Age (years) Asthmatic patients Control Group No.(%) Male Female No. Male Female 1 - <3 years 40(40%) 27(27%) 13(13%) 25(25%) 18(18%) 7(7%) 3 - <5 years 22(22%) 16(16%) 6(6%) 14(14%) 9(9%) 5(5%) 5 - <10 years 29(29%) 19(19%) 10(10%) 36(36%) 19(19%) 17(17%) 10-15 years 9(9%) 6(6%) 3(3%) 25(25%) 15(15%) 10(10%) Total 100(100%) 68(68%) 32(32%) 100(100%) 61(61%) 39(39%)
  • 15. The mean Serum Mg levels in Asthmatic and control group Groups No. (%) Serum Mg level(mg/dl) P-value Mean(±SD.) Asthmatic patient 100 1.91± 0.33 0.01 Controls 100 2.03± 0.33
  • 16. Comparison between Mg levels in Asthmatic and control group Serum Magnesium Asthmatic patients Control group Total Low S.Mg(<1.5 µg/dl) 9(9%) 1(1%) 10(5%) Normal S.Mg (1.5-2.3 mg/dL) 91(91%) 99(99%) 190(95%) Total 100(100%) 100(100%) 200(100%) X2=8.36 df=2 P=0.01
  • 17. Comparison between mean Serum Serum Magnesium levels & severity of Asthma. Severity of Asthma No. (%) Serum Mg level( mg/dl) P-value Mean(±SD.) Intermittent 67(67%) 1.96±0.33 0.05 Mild persistent 20 (20%) 1.85±0.26 Moderate persistent 10 (10%) 1.79±0.42 Severe persistent 3(3%) 1.50±0.10 Total 100 (100%) 1.91±0.33
  • 18. Comparison between mean Magnesium levels & duration of Asthma. Duration of Asthma No.(%) Serum Mg level( mg/dl) P-value Mean(±SD.) < 1 year 28 (28%) 1.97±0.27 0.1 1 - <3 years 48 (48%) 1.91±0.33 3- <5 years 11 (11%) 1.87±0.36 >5 years 13 (13%) 1.72±0.44 Total 100 (100%) 1.91±0.33
  • 19. The relation between mean Serum Magnesium and BMI of Asthmatic patients BMI No. Serum D3 level(µg/dl) P- value Mean(±SD.) Under weight <5% 21(21%) 1.97±0.25 0.3 Normal 5% to 85% 57 (57%) 1.90±0.36 Overweight 85% to 95% 13 (13%) 1.78±0.30 Obese >95% 9 (9%) 2.00±0.32 Total 100 (100%) 1.91±0.33
  • 20. The Comparison between mean Serum Magnesium levels & use of medications (controller) in Asthmatics. Drugs No.(%) Serum Mg level ( mg/dl) P-value Mean(±SD.) Steroid as controller medications Used steroid 20 (20%) 1.92±0.37 0.7 Not used steroid 80 (80%) 1.90±0.30 Bronchodilators as controller medications Use 31 (31%) 1.91±0.34 0.9 Not used 59 (59%) 1.90±0.31 Total 100(100%) 1.91±0.33
  • 21.
  • 22. Prevalence of Low Mg Level in Asthmatic patients Serum Magnesium level was found to be significantly lower in asthmatic children as compared to the control group Ukraine Egypt Turkey No significant differences between patients and controls Spain Iran
  • 23. Possible Explanation of Magnesium Deficiency in Asthmatics • Magnesium is the cofactor of more than 300 enzymes and is involved in many physiological functions including protein synthesis, intracellular signal distribution and enzyme catalysis. • Since it is the natural antagonist of calcium, it provides smooth muscle relaxation • In addition, magnesium suppresses the excitability of muscle fibers by reduction of acetylcholine secretion from motor nerve terminals. • Moreover, it inhibits production of inflammatory mediators by helping stabilization of T-cells and inhibiting mast cell degranulation. • Again, it reduces the severity of inflammation in asthma by stimulating nitric oxide and prostacyclin syntheses.
  • 24. Possible Explanation of Magnesium Deficiency in Asthmatics • Although the cause of hypomagnesemia in patients with bronchial asthma was unknown, • It may be related to either low magnesium intake in asthmatics or increased urinary loss of magnesium, as a side effect of therapy with b2- agonist, corticosteroid, and theophylline.
  • 26. Conclusions • Asthmatic Patients have significantly lower mean Serum Mg levels compared with healthy controls. • There is significant difference between mean Serum Mg levels AND severity of asthma. • Serum Mg level inversely correlates with the duration of asthma but not significantly. • But no statistically significant association were observed between Serum Mg and BMI. • No significant change in serum Mg develops with the use of steroids and bronchodilators in treatment.
  • 27. Recommendations • Magnesium supplementation might be considered a useful additional intervention for improving outcome in patients with Asthma. • A large follow up study is recommended to look on the effect of Magnesium supplementation in Asthmatic patients. • Further extended cohort study is indicated to look on the relations between the Asthmatic patients and serum Magnesium level.